Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice

Cancer Research

Volumn 56, Issue 10, 1996, Pages 2428-2433

  Min, Hye Yeong ^a   Doyle, Laura V ^a   Vitt, Charles R ^a   Zandonella, Catherine L ^a   Stratton Thomas, Jennifer R ^a   Shuman, Marc A ^b   Rosenberg, Steven ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; MATRIGEL; UROKINASE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; MELANOMA; METASTASIS; MOLECULAR CLONING; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN PURIFICATION; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR GROWTH;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELLS, CULTURED; CLONING, MOLECULAR; COLLAGEN; DNA, COMPLEMENTARY; DRUG COMBINATIONS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; EPITOPES; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOGLOBULIN G; LAMININ; LYMPHOKINES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PATHOLOGIC; NUCLEOPOLYHEDROVIRUS; PEPTIDE FRAGMENTS; PROTEOGLYCANS; RECEPTORS, CELL SURFACE; RECOMBINANT FUSION PROTEINS; URINARY PLASMINOGEN ACTIVATOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0001453577     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Folkman, J Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1. 27-31, 1995
2. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo Nature (Lond.), 362: 841-844, 1993.
3. Millauer, B., Shawver, L. K., Plate, K H , Risau, W , and Ullrich, A. Glioblastoma growth inhibited in vivo by a dominant negative Flk-1 mutant. Nature (Lond.), 367: 576-579, 1994.
4. Moscatelli, D , and Rifkin, D. B. Membrane and matrix localization of proteases: a common theme in tumor invasion and angiogenesis. Biochim. Biophys. Acta, 948: 67-85, 1988.
5. Saksela, O., Moscatelli, D., and Rifkin, D. B. The opposing effects of basic fibroblast growth factor and transforming growth factor β on the regulation of plasminogen activator activity in capillary endothelial cells. J Cell Biol., 105: 957-963, 1987.
6. Mignatti, P , Mazzieri, R., and Rifkin, D Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor J. Cell Biol , 113. 1193-1201, 1991.
7. Mandriota, S J , Seghezzi, G., Vasalli, J D , Ferrara, N., Wasi, S , Mazzieri, R., Mignatti, P., and Pepper, M. S. Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells J Biol. Chem., 270. 9709-9716, 1995.
8. Pepper, M. S , Sappino, A-P., Stocklin, R , Montesano, R , Orci, L , and Vassalli, J-D. Upregulation of urokinase receptor expression on migrating endothelial cells. J. Cell Biol., 122: 673-684, 1993
9. Yasunaga, C., Nakashima, Y , and Sueishi, K A rold of fibrinolytic activity in angiogenesis. Lab Invest., 61: 698-704, 1989.
10. Kristensen, P , Eriksen, J , Blasi, F., and Dano, K Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract J Cell Biol., 115: 1763-1771, 1991.
11. Grussenmeyer, T., Scheidtmann, K. H , Hutchinson, M. A., Eckhart, W., and Walter, G. Complexes of polyoma virus medium T antigen and cellular proteins Proc Natl Acad Sci USA, 82. 7952-7954, 1985.
12. Stratton-Thomas, J. R., Min, H. Y., Kaufman, S. E., Chiu, C. Y., Mullenbach, G. T., and Rasenberg, S Yeast expression and phagemid display of the human urokinase plasminogen activator epidermal growth factor-like domain. Prot. Eng., 8. 463-470, 1995.
13. Ellison, J. W., Berson, B J , and Hood, L. E. The nucleotide sequence of a human immunoglobulin Cg1 gene. Nucleic Acids Res., 10: 4071-4179, 1982
14. Munemitsu, S., Innis, M. A., Clark, R., McCormick, F., Ullrich, A., and Polakis, P. Molecular cloning and expression of a G25K cDNA, the human homolog of the yeast cell cycle gene CDC42. Mol. Cell Biol., 10: 5977-5982, 1990.
15. Gill, S. C., and Hippel, P. H v. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem., 182: 319-326, 1989.
16. Levin, J., and Bang, F B The role of endotoxin in the extracellular coagulation of Limulus blood. Bull Johns Hopkins Hosp., 115: 265-274, 1964.
17. Mann, W. B , and Whitney, D. R. On a test of whether one of two random variables is stochastically larger than the other. Ann. Math. Statis , 18: 52-54, 1947.
18. Estreicher, A., Wohlwend, A., Belin, D., Schleuning, W. D., and Vassalli, J-D. Characterization of the cellular binding site for the urokinase-type plasminogen activator. J. Biol. Chem., 264: 1180-1189, 1989.
19. Dubois-Stringfellow, N., Jonczyk, A , and Bautch, V. L. Perturbations in the fibrinolytic pathway abolish cyst formation but not capillary-like organization of cultured murine endothelial cells. Blood, 83: 3206-3217, 1994.
20. Kibbey, M. C., Grant, D. S., and Kleinman, H. K. Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo Matrigel model. J. Natl. Cancer Inst., 84: 1633-1638, 1992.
21. Fridman, R., Kibbey, M. C., Royce, L. S., Zain, M., Sweeney, T. M., Jicha, D. L., Yannelli, J. R., Martin, G. R., and Kleinman, H. K Enhanced tumor growth of both primary and established human and tumor cells in athymic mice after coinjection with Matrigel. J. Natl. Cancer Inst., 83: 769-774, 1991.
22. Crowley, C. W., Cohen, R. L., Lucas, B. K., Liu, G , Shuman, M. A., and Levinson, A. D. Prevention of metastsis by inhibition of the urokinase receptor. Proc. Natl. Acad Sci. USA, 90: 5021-5025, 1993.
23. Mazar, A. P., Buko, A., Petros, A. M., Barnathan, E. S., and Henkin, J Domain analysis of urokinase plasminogen activator (u-PA): preparation and characterization of intact A-chain molecules. Fibrinolysis, 6(Suppl 1). 49-55.
24. Fazioli, F., and Blasi, F. Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy? Trends Pharmacol. Sci , 15. 25-29, 1994.
25. Bacharach, E., Itin, A., and Keshet, E. In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc Natl. Acad. Sci. USA, 89: 10686-10690, 1992.
26. deVries, T. J., Kitson, J. L., Silvers, W. K., and Mintz, B. Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice Cancer Res., 55: 4681-4687, 1995
27. Foekens, J. A., Schmitt, M., vanPutten, W L., Peters, H. A , Kramer, M. D., Janicke, F., and Klijn, J. G Plasminogen activator inhibitor-1 and prognosis in primary breast cancer J. Clin Oncol., 12: 1648-1658, 1994.
28. Bianchi, E , Cohen, R. L., Thor, A. T., Todd, R. F., III, Mizukami, I. F., Lawrence, D. A , Ljung, B. M., Shuman, M. A , and Smith, H. S. The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res., 54: 861-866, 1994.
29. Hildenbrand, R. Dilger, I., Horlin, A., and Stutte, H. J. Urokinase and macrophages in tumour angiogenesis. Br. J. Cancer, 72: 818-823, 1995.
30. Ossowski, L , and Reich, E. Antibodies to plasminogen activator inhibit human tumor metastasis. Cell, 35. 611-619, 1983.
31. Ossowski, L , Russo-Payne, H., and Wilson, E. L. Inhibition of urokinase-type plasminogen activator by antibodies: the effect on dissemination of a human tumor in the nude mouse Cancer Res., 51: 274-281, 1991
32. Kobayashi, H., Gotoh, J., Shinohara, H., Moniwa, N., and Terao, T. Inhibition of the metastasis of Lewis lung carcinoma by antibody against urokinase-type plasminogen activator in the experimental and spontaneous metastasis model. Thromb Haemostasis, 71. 474-480, 1994.
33. deVries, T J., Quax, P H., Denijn, M., Verrijp, K N., Verheijen, J. H., Verspaget, H. W., Weidle, U. H., Ruiter, D. J , and van Muijen, G. N Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression Am. J. Pathol , 144 70-81, 1994.
34. Liu, G , Shuman, M., and Cohen, R L. Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells. Int. J. Cancer, 60: 501-506, 1995.
35. Loskutoff, D J., Sawdey, M., Keeton, M. and Schneiderman, J Regulation of PAI-1 gene expression in vivo. Thromb Haemost., 70: 135-137, 1993
36. Naldini, L , Vigna, E., Bardelli, A., Follenzi, A , Galimi, F , and Comoglio, P. M. Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stochiometric reaction. J. Biol. Chem , 270: 603-611, 1995.
37. Houck, K A., Leung, D W., Rowland, A M., Winer, J., and Ferrara, N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol. Chem , 267: 26031-26037, 1992
38. Min, H. Y., Semnani, R., Mizukami, I. F., Watt, K., Todd, R F., and Liu, D Y. cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator. J Imunol., 148: 3636-3642, 1992.
39. Wei, Y., Waltz, D. A., Rao, N., Drummond, R J., Rosenberg, S., and Chapman, H. A. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol Chem , 209. 32380-32388, 1994.
40. Odekon, L. E., Sato, Y , and Rifkin, D B Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity J. Cell. Physiol., 150. 258-263, 1992.